SG Americas Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $569K | Sell |
71,000
-102,800
| -59% | -$104M | ﹤0.01% | 2104 |
|
|
2025
Q4 | $2.38M | Buy |
173,800
+153,800
| +769% | +$147M | ﹤0.01% | 1424 |
|
|
2025
Q3 | $854K | Buy |
+20,000
| New | +$14.9M | ﹤0.01% | 1620 |
|
|
2025
Q2 | – | Sell |
-175,000
| Closed | -$7.91M | – | 3299 |
|
|
2025
Q1 | $7.91M | Buy |
+175,000
| New | +$146M | 0.03% | 362 |
|
|
2023
Q2 | – | Sell |
-55,000
| Closed | -$87K | – | 2772 |
|
|
2023
Q1 | $87K | Buy |
+55,000
| New | +$18.5M | ﹤0.01% | 2957 |
|
|
2022
Q4 | – | Sell |
-43,800
| Closed | -$149K | – | 3232 |
|
|
2022
Q3 | $149K | Buy |
43,800
+33,500
| +325% | +$10.6M | ﹤0.01% | 2556 |
|
|
2022
Q2 | $15K | Hold |
10,300
| – | – | ﹤0.01% | 3352 |
|
|
2022
Q1 | $31K | Sell |
10,300
-1,700
| -14% | -$438K | ﹤0.01% | 2873 |
|
|
2021
Q4 | $57K | Buy |
+12,000
| New | +$3.04M | ﹤0.01% | 3175 |
|
|
2021
Q2 | – | Sell |
-60,600
| Closed | -$176K | – | 3067 |
|
|
2021
Q1 | $176K | Buy |
60,600
+50,300
| +488% | +$9.84M | ﹤0.01% | 2756 |
|
|
2020
Q4 | $3K | Hold |
10,300
| – | – | ﹤0.01% | 3278 |
|
|
2020
Q3 | $117K | Hold |
10,300
| – | – | ﹤0.01% | 2394 |
|
|
2020
Q2 | $115K | Buy |
+10,300
| New | +$1.58M | ﹤0.01% | 3284 |
|
|
2019
Q4 | – | Sell |
-14,000
| Closed | -$26K | – | 3368 |
|
|
2019
Q3 | $26K | Buy |
+14,000
| New | +$1.56M | ﹤0.01% | 2886 |
|
|
2019
Q2 | – | Sell |
-368,300
| Closed | -$268K | – | 3278 |
|
|
2019
Q1 | $268K | Buy |
368,300
+288,300
| +360% | +$35.1M | ﹤0.01% | 2354 |
|
|
2018
Q4 | $10K | Sell |
80,000
-50,000
| -38% | -$5.59M | ﹤0.01% | 2944 |
|
|
2018
Q3 | $76K | Buy |
130,000
+50,000
| +63% | +$5M | ﹤0.01% | 2918 |
|
|
2018
Q2 | $114K | Hold |
80,000
| – | – | ﹤0.01% | 2992 |
|
|
2018
Q1 | $413K | Sell |
80,000
-74,700
| -48% | -$6.01M | ﹤0.01% | 1983 |
|
|
2017
Q4 | $245K | Buy |
154,700
+50,000
| +48% | +$4.25M | ﹤0.01% | 2312 |
|
|
2017
Q3 | $128K | Hold |
104,700
| – | – | ﹤0.01% | 2997 |
|
|
2017
Q2 | $187K | Buy |
104,700
+10,000
| +11% | +$816K | ﹤0.01% | 2486 |
|
|
2017
Q1 | $228K | Sell |
94,700
-157,800
| -62% | -$12.6M | ﹤0.01% | 2347 |
|
|
2016
Q4 | $680K | Buy |
252,500
+94,700
| +60% | +$7.05M | 0.01% | 1517 |
|
|
2016
Q3 | $354K | Buy |
157,800
+30,000
| +23% | +$2.4M | ﹤0.01% | 2013 |
|
|
2016
Q2 | $195K | Sell |
127,800
-1,005,600
| -89% | -$75.7M | ﹤0.01% | 2127 |
|
|
2016
Q1 | $8.79M | Buy |
+1,133,400
| New | +$85.8M | 0.06% | 233 |
|
|
2015
Q1 | – | Sell |
-73,400
| Closed | -$1K | – | 2843 |
|
|
2014
Q4 | $1K | Hold |
73,400
| – | – | ﹤0.01% | 3146 |
|
|
2014
Q3 | $6K | Hold |
73,400
| – | – | ﹤0.01% | 2589 |
|
|
2014
Q2 | $16K | Hold |
73,400
| – | – | ﹤0.01% | 2465 |
|
|
2014
Q1 | $42K | Sell |
73,400
-140,500
| -66% | -$7.84M | ﹤0.01% | 2322 |
|
|
2013
Q4 | $180K | Buy |
213,900
+92,900
| +77% | +$4.65M | ﹤0.01% | 2090 |
|
|
2013
Q3 | $32K | Buy |
121,000
+20,000
| +20% | +$1.05M | ﹤0.01% | 2850 |
|
|
2013
Q2 | $82K | Buy |
+101,000
| New | +$5.5M | ﹤0.01% | 2125 |
|
Other funds holding LLY
VCM
VPM
SG Americas Securities's LLY Position: Q1 2026 in Review
SG Americas Securities increased its Eli Lilly (LLY) stake by 155% in Q1 2026, buying an estimated $402M and bringing the position to 652,281 shares worth $600M. The position accounts for 0.65% of the portfolio, ranked #21.
SG Americas Securities first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- SG Americas Securities held 652,281 shares of Eli Lilly worth $600M as of Q1 2026.
- SG Americas Securities bought 396,357 Eli Lilly shares in Q1 2026, an estimated $402M.
- Eli Lilly made up 0.65% of SG Americas Securities's portfolio in Q1 2026, its #21 holding.
- SG Americas Securities first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.